Type 2 diabetes is a common condition managed in primary care. Although clinical practice guidelines recommend specific targets for blood pressure, lipids and HbA1c, primary care research has demonstrated only a small portion of patients with type 2 diabetes are meeting these targets. With the management of type diabetes, clinicians are still encouraged to work with patients to meet glycaemic targets, but there is an increased focus on a holistic assessment of the patient to reduce the risk of cardiorenal outcomes. This module will focus on providing recommendations on the intensification of antihyperglycaemic therapy beyond metformin in people with type 2 diabetes.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.